Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

OTHER_GOV × Cholangiocarcinoma × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Cholangiocarcinoma 2 Triple Negative Breast Neoplasms 1 Sarcoma, Kaposi 1 Prostatic Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Leukemia, Myeloid, Acute 1 Breast Neoplasms 1

Interventions

Gemcitabine 2 Everolimus 2 sintilimab 1 S 1 (combination) 1 Radiofrequency Ablation 1 Radiation 1 Neoadjuvant Therapy 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Congresses as Topic 1 Capecitabine 1 Ambulatory Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01525719 2012-02-03

CRAD001T

Ratchavithi Hospital

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma

NCT00973713 2009-09-09

RADiChol

Austin Health

Phase 2 Unknown

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡